ElectroCore has filed a patent for a device that treats patients by delivering electrical impulses through the skin to a selected nerve. The device, which includes a patch with electrodes and a wireless energy source, is designed to alleviate symptoms following major surgery or during intensive care treatment. The stimulation protocol involves administering daily doses lasting between 60 seconds and 5 minutes for multiple days. GlobalData’s report on ElectroCore gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on ElectroCore, cardiac stimulation implants was a key innovation area identified from patents. ElectroCore's grant share as of September 2023 was 65%. Grant share is based on the ratio of number of grants to total number of patents.
A device for transcutaneous electrical nerve stimulation (tens) treatment
A recently filed patent (Publication Number: US20230277838A1) describes a device for treating patients using electrical impulses transmitted through the skin to a selected nerve. The device consists of a patch with adhesive electrodes and a wireless energy source. The energy source generates electrical impulses and transmits them through the patient's skin to the targeted nerve according to a stimulation protocol. The protocol involves administering multiple doses each day for several days, with each dose lasting between sixty seconds to five minutes.
The patent claims also mention that the selected nerve for stimulation is the vagus nerve, and the patch is designed to be attached to the patient's neck. Additionally, the device includes a controller that transmits parameters for the stimulation protocol to the energy source. The stimulation protocol can include at least two doses per day, separated by a time frame of one hour to twelve hours. The protocol can also consist of 2 to 12 treatments per day.
The electrical impulses generated by the device are intended to modify post-operative symptoms, reduce inflammation, inhibit the release of pro-inflammatory cytokines, reduce post-operative pain, and alleviate symptoms of post-operative ileus. The electrical impulses can be in the form of pulses with a frequency ranging from 1 kHz to 20 kHz or bursts of pulses with each burst having a frequency of 1 to 100 bursts per second and each pulse lasting between 50 to 1000 microseconds. The bursts can consist of 2 to 20 pulses separated by an inter-burst period with zero pulses.
In addition to the device, the patent also describes a system for treating patients. The system includes the patch with adhesive electrodes, a software application that stores the stimulation protocol, and a mobile device. The energy source is wirelessly coupled to the electrodes and the mobile device. The energy source can be housed within the mobile device or be remote from it but still connected.
Overall, this patent describes a device and system for treating patients using electrical impulses transmitted through the skin to a selected nerve. The device aims to modify post-operative symptoms, reduce inflammation, and alleviate pain. The system includes a software application for storing the stimulation protocol and a mobile device for controlling the energy source.
To know more about GlobalData’s detailed insights on ElectroCore, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
